Galaxy Medicare P/E Ratio
Current P/E Ratio
8.27
Low Valuation
Very Low - Potentially undervalued or facing challenges
Galaxy Medicare (GML) P/E ratio is 8.27 (Low), EPS (TTM) ₹2.25, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see Galaxy Medicare share price today.
Current Valuation Metrics
P/E Ratio
8.27
Current Price
₹
EPS (TTM)
₹2.25
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
55.12
Sector Median
30.97
Sector Rank
#11 of 198
Sector Percentile
5.6%
GML P/E Ratio — Valuation Signal & Historical Context
Galaxy Medicare P/E 8.27 — signal: Undervalued. Compare with Galaxy Medicare valuation methods to assess whether the stock is under or overvalued.
- Stock appears undervalued with PE of 8.27, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.12
GML vs Healthcare Peers — P/E Ratio Comparison
Galaxy Medicare P/E 8.27 vs Healthcare average 55.12, median 30.97 — range 2.86–706.0.
Sector Average
55.12
Sector Median
30.97
Lowest P/E
2.86
Highest P/E
706.0
Companies
198
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 2.98 | ₹52 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |